Not applicableUnknownNCT05256121What this trial is testingHAPPCAP-AD (Human-APPlication Combined Approach for Prevention of Alzheimer's Disease)Who this might be right forAlzheimer Disease Sheba Medical Center 100
Early research (Phase 1)Study completedNCT01565343What this trial is testing18F-AV-45 in Alzheimer's Disease (AD) and Healthy VolunteersWho this might be right forAlzheimer's Disease Avid Radiopharmaceuticals 25
Not applicableNot Yet RecruitingNCT07230158What this trial is testingTranscranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease II (TRANSFORM-AD II)Who this might be right forAlzheimer Disease Xuanwu Hospital, Beijing 160
Testing effectiveness (Phase 2)Study completedNCT00151333What this trial is testingStudy Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)Who this might be right forAlzheimer's Disease Wyeth is now a wholly owned subsidiary of Pfizer 16
Testing effectiveness (Phase 2)Study completedNCT05617508What this trial is testingN-DOSE AD: A Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseDementia Haukeland University Hospital 80
Not applicableStudy completedNCT06368115What this trial is testingA Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2Who this might be right forAlzheimer Disease University of Massachusetts, Worcester 11,375
Not applicableNot Yet RecruitingNCT07347574What this trial is testingNeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HKWho this might be right forAD - Alzheimer's DiseaseMild Cognitive ImpairmentNormal Cognition+1 more Hong Kong University of Science and Technology 2,500
Not applicableLooking for participantsNCT05877196What this trial is testingA SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness ResponsesWho this might be right forMild Cognitive ImpairmentAlzheimer DiseaseCognitive Impairment+3 more Arizona State University 216
Not applicableLooking for participantsNCT05205980What this trial is testingPerturbation Training Reduces Falls in People With Alzheimer's Disease (AD)Who this might be right forAlzheimer Disease Georgia State University 30
Early research (Phase 1)Ended earlyNCT03935568What this trial is testingA Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy SubjectsWho this might be right forAlzheimer's Disease Samus Therapeutics, Inc. 40
Not applicableLooking for participantsNCT06924359What this trial is testingMultimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's DiseaseWho this might be right forAlzheimer's Disease (AD) Peking University First Hospital 200
Early research (Phase 1)Study completedNCT00733642What this trial is testingSingle Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 15
Testing effectiveness (Phase 2)Looking for participantsNCT07094516What this trial is testingA Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Novartis Pharmaceuticals 407
Post-approval studies (Phase 4)Study completedNCT00035204What this trial is testingThe Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Not applicableLooking for participantsNCT03954899What this trial is testingDisease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in AgingWho this might be right forMild Cognitive ImpairmentCognitive DeclineHealthy Aging Natalie Denburg 230
Large-scale testing (Phase 3)Study completedNCT05686044What this trial is testingA Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADWho this might be right forAlzheimer Disease Annovis Bio Inc. 351
Large-scale testing (Phase 3)Ended earlyNCT03114657What this trial is testingCrenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)Who this might be right forAlzheimer's Disease Hoffmann-La Roche 806
Not applicableLooking for participantsNCT05911932What this trial is testingInvestigating Genetic Status in Patients Presenting to ClinicWho this might be right forDementia, FrontotemporalAlzheimer Dementia (AD)Lewy Body Dementia (LBD) London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1,000
Large-scale testing (Phase 3)Ended earlyNCT04374253What this trial is testingEvaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)Who this might be right forAlzheimer Disease Hoffmann-La Roche 1,382
Early research (Phase 1)Study completedNCT06114745What this trial is testingA Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's DiseaseWho this might be right forAlzheimer's Disease (AD) Atridia Pty Ltd. 2